|
Congressional:
Senate Special Aging Committee Holds Hearing on Foreign Dependence for Prescription Drugs
On Wednesday, the Senate Special Committee on Aging held a hearing examining the U.S.’s dependency on foreign nations for prescription drugs. The hearing focused on the dependence on China for drug ingredients and finished products. Chair Rick Scott (R-FL) and Ranking Member Kirsten Gillibrand (D-NY) stressed their concern about the national security risk and the quality of drugs imported from China. There was also bipartisan support for the Clear Labels Act, which would increase transparency in the drug supply chain, as well as the importance of reshoring or “friend-shoring” some pharmaceutical manufacturing, while building trusted supply networks. Read Mehlman’s hearing summary here.
Joint Economic Committee Releases Issue Brief on Part B Premium Pass-Through
On Tuesday, the Joint Economic Committee released an issue brief asserting that Medicare Advantage (MA) overpayments increased Part B premiums by $212 per enrollee in 2025, totaling $13.4 billion. Read the issue brief here.
House E&C Leaders Expand Investigation into Medicaid Fraud Nationwide
Late last week, on Thursday, Representatives Brett Guthrie (R-KY), Chairman of the House Committee on Energy and Commerce, John Joyce, M.D. (R-PA), Chairman of the Energy and Commerce Subcommittee on Oversight and Investigations, and Morgan Griffith (R-VA), Chairman of the Energy and Commerce Subcommittee on Health, announced their continued investigation into waste, fraud, and abuse within Medicaid programs by sending letters to ten additional states to request information and documents on the actions each state is taking to strengthen Medicaid program integrity. The Committee sent letters to California, Colorado, Massachusetts, Maine, Nebraska, New York, Oregon, Pennsylvania, Vermont, and Washington. Read the press release here.
Notable Bills:
House E&C Chairman Brett Guthrie Reintroduces Bipartisan Legislation to Expand Access to Treatment for Rare Diseases
On Tuesday, Representative Brett Guthrie (R-KY), Chairman of the House Committee on Energy and Commerce, introduced the Medicaid VBPs for Patients (MVP) Act alongside Representatives Jake Auchincloss (D-MA), John Joyce, M.D. (R-PA), Scott Peters (D-CA), Mariannette Miller-Meeks (R-IA), and Don Davis (D-NC). The legislation would improve vulnerable populations’ access to innovative treatments and cures by enabling states to voluntarily enter into value-based purchasing (VBP) agreements, which tie treatment costs to patient outcomes. Read the press release here and the bill here.
Senators Young & Luján Introduce Bill to Ensure American Leadership in AI and Biotech
On Thursday, Senators Todd Young (R-IN), chair of the National Security Commission on Emerging Biotechnology (NSCEB), and Ben Ray Luján (D-NM) introduced the AI-Ready Bio-Data Standards Act. The legislation would direct the National Institute of Standards and Technology (NIST) to establish standards that will support American leadership in the convergence of artificial intelligence (AI) and biotechnology. Read the press release here and the bill here.
Representative Kelly Reintroduces Bipartisan Legislation to Improve Access to Healthy, Nutritious Food
On Thursday, Representatives Robin Kelly (D-IL) and Jen Kiggans (R-VA) introduced the Fueling Optimal Outcomes through Diet (FOOD) for Health Act. The legislation would direct the Secretary of Agriculture and the Secretary of Health and Human Services to provide grants to Food is Medicine programs that prioritize local foods and regional diversity. The bill would also authorize $20 million through fiscal year 2031 and require an initial report to Congress analyzing the efficiency and impact on patient outcomes and system costs. Read the press release here and the bill here.
Senators Shaheen and Collins Introduce Bipartisan Bill to Improve Access to Diabetes Treatments, Education for Medicare Beneficiaries
On Wednesday, Senators Jeanne Shaheen (D-NH) and Susan Collins (R-ME), Co-Chairs of the Senate Diabetes Caucus, introduced the Diabetes Interventions Addressing Barriers to Enrollment, Technology and Education Services (DIABETES) Act. The legislation would ensure that care for diabetic patients is not interrupted when they enroll in Medicare and would exempt insulin pumps and continuous glucose monitors (CGMs) from the Medicare competitive bidding process for 5 years. Read the press release here and the bill here.
Senators Scott & Booker Introduce Bill to Strengthen Wastewater Monitoring and Improve Pandemic Preparedness
On Wednesday, Senators Tim Scott (R-SC) and Cory Booker (D-NJ) introduced the Public Health Response and Emergency Detection through Integrated Wastewater Community Testing (PREDICT) Act, legislation to strengthen and expand the nation’s wastewater monitoring network and improve the early detection of infectious diseases. Senators Maggie Hassan (D-NH), Ted Budd (R-NC), Roger Wicker (R-MS), and Angus King (I-ME) are cosponsors. Read the press release here and the bill here.
Senator Husted Leads Bill to Combat Anti-competitive Health Care Practices
On Tuesday, Senator Jon Husted (R-OH) introduced the bipartisan Healthy Competition for Better Care Act, which aims to ban anticompetitive clauses in health care contracting between payers and health care providers and hospitals. Representatives Jodey Arrington (R-TX), Rick Allen (R-GA), Donald Davis (D-NC), and Chuck Edwards (R-NC) introduced a companion bill in the House. Read the press release here and the bill here.
Representative Bilirakis & Colleagues Reintroduce the Promoting Fairness for Medicare Providers Act
On Monday, Representatives Gus Bilirakis (R-FL), Raul Ruiz, M.D. (D-CA), Greg Murphy, M.D. (R-NC), and Danny Davis (D-IL) reintroduced the Promoting Fairness for Medicare Providers Act. The legislation aims to correct inequities between office-based settings and ambulatory surgical centers by aligning Medicare payment rates for certain procedures with high supply costs across care settings. Read the press release here and the bill here.
Executive Branch:
CMS Strengthens Patient Protections and Accountability in Organ Donation System
On Wednesday, the Centers for Medicare & Medicaid Services (CMS) issued new guidance to strengthen public trust and ensure patients and their families are treated with dignity and care throughout the organ donation process. The guidance clarifies and reinforces the responsibilities of Organ Procurement Organizations (OPOs) and donor hospitals, both in providing patients with full medical care regardless of potential donor status and in allowing families time to make decisions regarding organ donation without coercion. Read the press release here.
Center for Biologics Evaluation and Research Director, Vinay Prasad, to Depart FDA
Late last week, on Friday, Food and Drug Administration (FDA) Commissioner Marty Makary announced that Vinay Prasad, director of the Center for Biologics Evaluation and Research, will leave the FDA at the end of April. In a post on X, Makary stated that the FDA will appoint a successor before Prasad returns next month to the University of California, San Francisco, where he taught before taking the FDA position last year.
FDA Approves First Treatment for Patients with Cerebral Folate Transport Deficiency
On Tuesday, the Food and Drug Administration approved expanded use of Wellcovorin (leucovorin calcium) tablets for the treatment of cerebral folate deficiency in adult and pediatric patients who have a confirmed variant in the folate receptor 1 gene (CFD-FOLR1). FDA Commissioner Marty Makary stated that "this action may benefit some individuals with FOLR1-related cerebral folate transport deficiency who have developmental delays with autistic features." Read the press release here.
|